IL-6, through induction of proinflammatory chemokines and cytokines, plays a critical role in the progression from mild inflammation to hyperinflammatory conditions, CRS, ARDS and corresponding lung damage causing mortality in critically ill COVID-19 patients [29,30]. Here, IL6 is linked to COVID-19.